About Leadscope
Leadscope is a Healthcare company based in Columbus (United States) founded in 1998, and was acquired by Instem in November 2019. Chemical toxicity assessment software and databases are provided. It operates on a SaaS (Software-as-a-Service) and Professional Services model in Healthcare and Technology sectors. Leadscope has raised $7.19 million across 3 funding rounds from investors including Pfizer, J P Morgan and Instem. The company has 6 employees. Leadscope offers products and services including Leadscope Model Applier, Provantis, SEND Advantage Services, and Accel. Its focus areas include Software, Life Sciences Software, Biotechnology and Research Tools. Its legal entity is Instem. Its competitors include Insitro, HotSpot Therapeutics and Certara; 2 of its 3 listed competitors have raised funding.
Company details
Software and services for life sciences are offered by Instem under the Leadscope brand. Focus is placed on SaaS platforms across discovery, study management, regulatory submission, and clinical trial analytics. Solutions for data management, predictive analytics, and real-time visualization are developed to support efficient and compliant research environments. Sectors such as pharmaceutical, biotechnology, and academic research are served with tools designed to accelerate studies and bring products to market. Innovation is prioritized to deliver value to clients and support their life-improving missions.
- Headquarters Columbus, United States
- Employees 6
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website leadscope.com
- Social LinkedIn X
- Acquired by Instem (Nov 2019)
- Legal Name Instem
Products & Services of Leadscope
Leadscope offers a comprehensive portfolio of products and services, including Leadscope Model Applier, Provantis, SEND Advantage Services, and Accel.
Software for predictive analytics in life science research.
Tool for preclinical data collection and analysis support.
Service for regulatory data validation and submission support.
Platform for accelerating clinical trial data analysis timelines.
Funding Insights of Leadscope
Leadscope has successfully raised a total of $7.19M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $185 thousand completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.19M
- Total Rounds 3
- Last Round Series C — $185,000
- Investors Count 4
All 3 funding rounds of Leadscope with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2008 | $185,000 | Series C | – | – | – |
| Jul 2000 | $7M | Series B | – | – | |
| Jun 1999 | Series A | – | – |
5 investors in total: 5 institutional.
Investors in Leadscope
Leadscope has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, J P Morgan and Instem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Acquisitions are targeted by MedEquity as a private equity firm. | medequity.com | Wellesley, United States | ||
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States | |
A wide array of financial services is provided by GE Commercial Finance. | gecommercialfinance.com | |||
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States | |
Software for life science data collection and analysis is provided. | 1969 | instem.com | Conshohocken, United States |
Investor details for Leadscope
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Leadscope
4 dated milestones of Leadscope across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Leadscope is founded.
- Funding First funding round.
- Funding Latest funding round, Series C, of $185K.
- Exit Acquired by Instem.
Competitors of Leadscope
Leadscope has 3 listed competitors in our database, 2 of them funded. They include Insitro, HotSpot Therapeutics and Certara.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| certara.com | 2008 | Princeton, United States | 827 | Provider of a platform for in silico drug discovery and consulting services |
Detailed competitors of Leadscope
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Leadscope
The website of Leadscope (leadscope.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 13.3% vs previous month
Websites whose visitors overlap most with Leadscope. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
multicase.com | multicase.com | 100% | – | ||
| lhasalimited.org | 100% | 12.2K | #1,940,895 | View details | |
download.com.com | download.com.com | 98% | – | ||
molecular-networks.com | molecular-networks.com | 76% | – | ||
| symyx.com | 69% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Leadscope (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leadscope
Complete news archive for Leadscope
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leadscope
Leadscope was founded in 1998 and raised its 1st funding round 1 year after it was founded.
Leadscope is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
Leadscope is a funded company, having raised a total of $7.19M across 3 funding rounds to date.
Leadscope has 6 employees.
Software and services for life sciences are offered by Instem under the Leadscope brand. Focus is placed on SaaS platforms across discovery, study management, regulatory submission, and clinical trial analytics. Solutions for data management, predictive analytics, and real-time visualization are developed to support efficient and compliant research environments. Sectors such as pharmaceutical, biotechnology, and academic research are served with tools designed to accelerate studies and bring products to market. Innovation is prioritized to deliver value to clients and support their life-improving missions.
Leadscope's top competitors include Insitro, HotSpot Therapeutics and Certara.
Leadscope offers Leadscope Model Applier, Provantis, SEND Advantage Services, and Accel.
Leadscope has 5 investors. Key investors include Pfizer, J P Morgan, Instem, MedEquity, and GE Commercial Finance.
Leadscope operates through Instem.
Yes. Leadscope was acquired by Instem in November 2019.